中文名：A922500,DGAT-1抑制剂
英文名：A922500
纯度：≥98%
货号：A129800
Cas号：959122-11-3
存储温度：-20°C储存
运输条件：超低温运输
产品介绍：
DGAT-1 inhibitor A 922500 (A-922500) reduces serum triglyceride levels from baseline at all doses tested; however, this is only statistically significant at the 3 mg/kg dose, which lowers serum triglycerides by 53%. Similarly, the 3 mg/kg dose of A 922500 significantly reduces serum FFA concentrations by 55% and total cholesterol by 25%. DGAT-1 inhibition has no significant effect on body weight at any dose tested. Although A 922500 dpes not significantly affect LDL-cholesterol or HDL-cholesterol individually, the serum LDL/HDL-cholesterol ratio is significantly improved by A 922500 at 0.3 and 3 mg/kg. Similar to the dyslipidemic hamster, treatment with 3 mg/kg A 922500 significantly reduces serum triglyceride concentrations (39%). FFA levels significantly increase over the 14-day period in vehicle-treated animals. This increase is inhibited in a dose-dependent manner by A 922500 such that FFA concentrations are 32% lower after 14 days of treatment with the DGAT-1 inhibitor at 3 mg/kg, compared with the vehicle group (p < 0.05). HDL-cholesterol is significantly increased from baseline levels by A 922500 at 0.3 and 3 mg/kg; however, this is only significantly increased compared with vehicle at the 3 mg/kg dose. Body weight significantly increases over the 2-week period in vehicle-treated rats, and this is not affected by A 922500. LDL-cholesterol is significantly reduced in the vehicle treated group. DGAT-1 inhibition does not further reduce LDL-cholesterol and has no effect on total cholesterol.
产品用途：
A922500 has been used in the inhibition of diacylglycerol acyltransferase (DGAT) in epithelial human breast cancer cell line (MDA-MB-231), digitonin-permeabilized human cancer cells, human myotubes and macrophages.
查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/A129800.html
关键字： (1R,2R)-2-[[4-[[(苯基氨基)羰基]氨基][1,1-联苯]-4-基]甲酰基]环戊烷羧酸;DGAT-1 Inhibitor 4a ; (1R,2R)-2-(4'-(3-Phenylureido)-[1,1'-biphenyl]-4-carbonyl)cyclopentanecarboxylic acid ; SCHEMBL2742723
阿拉丁（A股科创板上市企业，股票代码：688179） 是科研服务领域的领先供应商与制造商，拥有科学服务领域领导品牌：阿拉丁。核心业务涵盖高端化学与生化试剂、生命科学、小分子及化合物库及材料科学四大领域，并自主拥有“芯硅谷”实验耗材品牌，依托电商平台实现线上主导的销售模式 。产品广泛服务于985/211高校、科研院所及生物医药、化工材料等领域220余家A股上市公司。
国内以上海化工园区、奉贤基地为核心，建成超7.6万㎡现代化产业集群 ，拥有GMP车间满足高品质多元需求，并配备全国五大仓储中心。研发投入超3亿元，建有化学、生物两大研发中心，每年推出超10,000种新产品，截至2025年10月拥有178项知识产权 ，产品SCI引用超25.3万篇，稳居国内科研试剂文献TOP3 。
战略立足全球，已在美国、德国等多地设5个公司布局 ，连续获《国家级专精特新“小巨人”企业》 、《中国化学试剂十强企业》 、《最受用户欢迎试剂品牌》 等荣誉，秉承“推动发现，推进科学”的理念，助力科研创新。